Related references
Note: Only part of the references are listed.Serum apolipoproteins and apolipoprotein-defined lipoprotein subclasses: a hypothesis-generating prospective study of cardiovascular events in T1D
Arpita Basu et al.
JOURNAL OF LIPID RESEARCH (2019)
Increased apolipoprotein C3 drives cardiovascular risk in type 1 diabetes
Jenny E. Kanter et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Effects of APOC3 Heterozygous Deficiency on Plasma Lipid and Lipoprotein Metabolism
Gissette Reyes-Soffer et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2019)
Plasma Levels of Retinol Binding Protein 4 Relate to Large VLDL and Small LDL Particles in Subjects with and without Type 2 Diabetes
Hanna Wessel et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Serum RBP4 positively correlates with triglyceride level but not with BMI, fat mass and insulin resistance in healthy obese and non-obese individuals
Emilia Korek et al.
BIOMARKERS (2018)
High-Density Lipoprotein Subspecies Defined by Presence of Apolipoprotein C-III and Incident Coronary Heart Disease in Four Cohorts
Majken K. Jensen et al.
CIRCULATION (2018)
New markers of insulin resistance in polycystic ovary syndrome
K. Polak et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2017)
Serum RBP4 and CKD: Association with insulin resistance and lipids
Maria Alice M. Domingos et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2017)
Apolipoprotein C-III inhibits triglyceride hydrolysis by GPIHBP1-bound LPL
Mikael Larsson et al.
JOURNAL OF LIPID RESEARCH (2017)
Aromatic residues in the C terminus of apolipoprotein C-III mediate lipid binding and LPL inhibition
Nathan L. Meyers et al.
JOURNAL OF LIPID RESEARCH (2017)
Non-HDL-cholesterol and C-reactive protein in children and adolescents with type 1 diabetes
Maria Mercedes Prado et al.
JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM (2017)
Impact of Excessive Weight Gain on Cardiovascular Outcomes in Type 1 Diabetes: Results From the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study
Jonathan Q. Purnell et al.
DIABETES CARE (2017)
The relationship of blood glucose with cardiovascular disease ismediated over time by traditional risk factors in type 1 diabetes: the DCCT/EDIC study
Ionut Bebu et al.
DIABETOLOGIA (2017)
Antisense-Mediated Lowering of Plasma Apolipoprotein C-III by Volanesorsen Improves Dyslipidemia and Insulin Sensitivity in Type 2 Diabetes
Andres Digenio et al.
DIABETES CARE (2016)
Development and Validation of a Method to Estimate Insulin Sensitivity in Patients With and Without Type 1 Diabetes
Lindsey M. Duca et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
ApoC-III inhibits clearance of triglyceride-rich lipoproteins through LDL family receptors
Philip L. S. M. Gordts et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Relation of Combined Non-High-Density Lipoprotein Cholesterol and Apolipoprotein B With Atherosclerosis in Adults With Type 1 Diabetes Mellitus
Petter Bjornstad et al.
AMERICAN JOURNAL OF CARDIOLOGY (2015)
Association Between 7 Years of Intensive Treatment of Type 1 Diabetes and Long-term Mortality
Trevor J. Orchard et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
A Cluster of Proteins Implicated in Kidney Disease Is Increased in High-Density Lipoprotein Isolated from Hemodialysis Subjects
Baohai Shao et al.
JOURNAL OF PROTEOME RESEARCH (2015)
Antisense Inhibition of Apolipoprotein C-III in Patients with Hypertriglyceridemia
Daniel Gaudet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Humans With Atherosclerosis Have Impaired ABCA1 Cholesterol Efflux and Enhanced High-Density Lipoprotein Oxidation by Myeloperoxidase
Baohai Shao et al.
CIRCULATION RESEARCH (2014)
Update on Cardiovascular Outcomes at 30 Years of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study
John M. Lachin et al.
DIABETES CARE (2014)
Plasma triglycerides predict incident albuminuria and progression of coronary artery calcification in adults with type 1 diabetes: The Coronary Artery Calcification in Type 1 Diabetes Study
Petter Bjornstad et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2014)
Targeting APOC3 in the Familial Chylomicronemia Syndrome
Daniel Gaudet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Adiponectin Dysregulation and Insulin Resistance in Type 1 Diabetes
Rocio I. Pereira et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Obesity and Coronary Artery Calcium in Diabetes: The Coronary Artery Calcification in Type 1 Diabetes (CACTI) Study
Ticiana C. Rodrigues et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2011)
Increased risk of cardiovascular disease in Type 1 diabetes: arterial exposure to remnant lipoproteins leads to enhanced deposition of cholesterol and binding to glycated extracellular matrix proteoglycans
R. Mangat et al.
DIABETIC MEDICINE (2011)
Association of insulin sensitivity to lipids across the lifespan in people with Type 1 diabetes
D. M. Maahs et al.
DIABETIC MEDICINE (2011)
Complexities of plasma apolipoprotein C-III metabolism
Frank M. Sacks et al.
JOURNAL OF LIPID RESEARCH (2011)
Apolipoprotein C-III and the Metabolic Basis for Hypertriglyceridemia and the Dense Low-Density Lipoprotein Phenotype
Chunyu Zheng et al.
CIRCULATION (2010)
Insulin Resistance in Adolescents with Type 1 Diabetes and Its Relationship to Cardiovascular Function
Kristen J. Nadeau et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Retinol-binding protein 4 is associated with impaired glucose tolerance but not with whole body or hepatic insulin resistance in Mexican Americans
Alberto O. Chavez et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2009)
Impact of Type 1 Diabetes and Insulin Treatment on Plasma Levels and Fractional Synthesis Rate of Retinol-Binding Protein 4
Marion Jourdan et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Retinol-binding protein 4 is associated with components of the metabolic syndrome, but not with insulin resistance, in men with type 2 diabetes or coronary artery disease
M. von Eynatten et al.
DIABETOLOGIA (2007)
Circulating retinol-binding protein-4, insulin sensitivity, insulin secretion, and insulin disposition index in obese and nonobese subjects
Montserrat Broch et al.
DIABETES CARE (2007)
Retinol-binding protein 4 is associated with insulin resistance and body fat distribution in nonobese subjects without type 2 diabetes
Shai Gavi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Increased serum retinol-binding protein 4 concentrations in women with gestational diabetes mellitus
Te-Fu Chan et al.
REPRODUCTIVE SCIENCES (2007)
Primary prevention of cardiovascular diseases in people with diabetes mellitus - A scientific statement from the American Heart Association and the American Diabetes Association
John B. Buse et al.
DIABETES CARE (2007)
Plasma retinol-binding protein-4 concentrations are elevated in human subjects with impaired glucose tolerance and type 2 diabetes
Young Min Cho et al.
DIABETES CARE (2006)
Spectrum and prevalence of atherogenic risk factors in 27,358 children, adolescents, and young adults with type 1 diabetes
KO Schwab et al.
DIABETES CARE (2006)
Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes
Q Yang et al.
NATURE (2005)
ApoC-III bound to apoB-containing lipoproteins increase with insulin resistance in Cherokee Indian youth
PR Blackett et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2005)
Effect of type 1 diabetes on the gender difference in coronary artery calcification: A role for insulin resistance? The Coronary Artery Calcification in Type 1 Diabetes (CACTI) study
D Dabelea et al.
DIABETES (2003)
Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes
SP Laing et al.
DIABETOLOGIA (2003)
Insulin resistance-related factors, but not glycemia, predict coronary artery disease in type 1 diabetes - 10-year follow-up data from the Pittsburgh Epidemiology of Diabetes Complications study
TJ Orchard et al.
DIABETES CARE (2003)
Share Paper
